Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme


The relevance of angiogenesis inhibition in the treatment of glioblastoma multiforme (GBM) should be considered in the unique context of malignant brain tumours. Although patients benefit greatly from reduced cerebral oedema and intracranial pressure, this important clinical improvement on its own may not be considered as an anti-tumour effect. GBM can be… (More)
DOI: 10.1186/1471-2407-9-444


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Blog articles referencing this paper